Google Search

Search

Already a Member ?

Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Drug Intermediates, Speciality Chemicals, Raw Materials, Fine and Specialty Chemicals Intermediates, Pharmaceutical Bulk Drugs

Indian drugs and pharmaceutical industry has advanced perceptibly and is getting ready  for the new patent regime and  to withstand global competition, which is expected to be unleashed by new winds of liberalisation - a new era of liberalisation - much different from what was ushered in since the conclusion of the Uruguay Round and the establishment of the World Trade Organisation.

The industry has been expanding at annual rates ranging between 8 to 10% (against global growth rate of 6%).  According to a study  by McKinsey, Vision 2010, the domestic pharmaceutical industry could attain a size of  $25 billion (Rs 1200 billion) by 2010 by focusing on two areas: first, innovation-led research, development and new drug discoveries; and second, information technology-led remote sales and marketing.  The market for bulk drugs and formulations had increased from about Rs 103  billion in 1990-91 to an estimated Rs 435  billion at the end of 2003-04.  The prices of Indian essential drugs are among the lowest in the world. Apart from strides made by the industry in the last half-a-century, lower production cost due to reverse engineering and low R&D outlays has been a major factor in keeping the prices under check.

The global pharmaceutical industry is estimated at $ 300 billion, not all representing cross-border trade.  India's measly share of $ 1.5 billion in global trade represents an untapped potential. Under the regime of economic liberalisation underway since early 1990s, the drugs and pharmaceutical sector witnessed initiatives at fresh investment in the sector. Nearly 1735 investment proposals of the order of around Rs 166  billion were initiated. The foreign collaboration proposals approved numbered around 425 with a foreign direct investment  (FDI) component of over Rs 25 billion. The pharmaceuticals have figured high on the export front. In 2001-02,  the sector was  estimated to have registered a growth of 17.6% at around Rs 20.3 billion.

In the wake of economic liberalisation, many a  overseas players  returned or contemplated returning to India. These include Ivox Corp (USA),  Taro Pharmaceuticals (Israel) and Merck (USA). These are out either to set shop or looking for acquisitions in India. Hexal AG of Germany has established a liaison office in India. MILLIONCs like Rocha, Bayer, Aventis and Chiron are making India a regional hub for bulk drugs. 

The Export Import Bank of India (Exim Bank) had  doubled its corpus for the pharmaceutical industry to Rs 2 billion as a result of increased activity in the industry, especially in the external sector. The fund is used for the development and commercialisation of the new products and applications, significant improvement in the existing design of  products, setting up and expansion of pilot plants, research studies for obtaining regulatory approvals, cost of filing and managing international patent and R&D Centres.

It needs, however, to be recognised that the presence  of small scale manufacturers has resulted, on the one hand,  in a highly fragmented industry, and on the other, it has made it possible to supply a near 100,000 drugs including vitamins, antibiotics, antibacterials, cardio-vascular and other essential drugs. These account for nearly 37% of the market.  While each of about 80% of the manufacturers has annual sales below a billion rupees, top ten companies are known to control over 30% of the market. At present there are more than 20,000 players in the country.

The major players are: Alembic Chem, Aurobindo Pharma, Cipla, Dr. Reddy's, FDC, IPCA Labs, Jagsonpal Pharma, J.B. Chemicals, Kopran, Lupin Labs, Lyka Labs, Morepan Labs, Nicholas Piramal, Ranbaxy Labs, Sun Pharma, Themis Medicare, GlaxoSmithkline, Astrazeneca, Aventis, E-Merck, Torrent Pharma, TTK Healthcare, Unichem Labs,  Wockhardt  and  Zandu Pharma.  Until recently, only a few of the Indian companies had gone into any serious R&D activity. Much of the effort was directed to affordable analogue research. The R&D level in the country is low with even well-placed pharma companies spending less than 2% of turnover on R&D. MILLIONCs are known to contribute as much as 10% or more of their turnover to R&D.  While India is very strong in process chemistry, biology and applied bio-chemistry, initiatives at all levels - government, academia, private sector - involving heavy financial outlays, are called for.

Ayurveda continues to remain a preferred system of medicine for a vast segment of population in the country. The country has over 400,000 registered practitioners of the Indian system of medicine. Around 170 institutes properly affiliated to various universities impart under- or post-graduate courses each year. These institutes churn out some 5,500 fresh practitioners. The practitioners are supported by 12,000 dispensaries and 2,100 beds available for ayurveda treatment countrywide. The emerging biotechnology sector has already taken by storm and is offering sops to states to make these as the thriving ground for the highly potential segment in medicare.

We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

We can modify the project capacity and project cost as per your requirement.
We can also prepare project report on any subject as per your requirement.

Page 19 of 20 | Total 199 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20   Next »

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Select all | Clear all Sort by

Empty Gelatin Capsules

Gelatin capsules, informally called gel caps or gelcaps, are composed of gelatin manufactured from the collagen of animal skin or bone. Capsules offer a viable alternative to tablets as an oral delivery of therapeutic compounds. Empty capsules are oral dosage forms, which based on the type of manufacturing material, come in variety of sizes and colors such as pearl capsules and flavored capsules. There are various types of capsules such as soft gelatin capsules, hard gelatin capsules, sustained release capsules, enteric coated capsules, and rectal capsules. Soft and hard gelatin capsules are widely used empty capsules. Empty capsules are available in five sizes, which includes 00, 0, 1, 2, and 3 and each sized capsule can hold different quantity of active pharmaceutical ingredients. These capsules are differentiated on the basis of the amount of active pharmaceutical ingredient they can hold. For instance, 0 sized capsule can hold up to 500 mg and 3 holds about 200 mg of active pharmaceutical ingredient. Gelatin is widely used in the empty capsules market due to its softness, lack of a notable odor or taste, and stability across a wide temperature range. However, growing opposition to animal-derived gelatin in economically crucial markets such as India, where vegetarianism is the norm, is likely to lead to significant product development in the global empty capsules market in the coming years. The global empty capsules market is projected to reach USD 2.79 billion by 2023 from USD 1.95 billion in 2018, at a CAGR of 7.4%. The growing adoption of capsule formulations among the growing geriatric population, growth of the pharmaceutical market along with the increasing R&D activities & clinical trials, and advancements in capsule delivery technologies are some of the major factors driving the growth of the market. The empty capsules market is a key part of the global pharmaceutical industry and is likely to exhibit steady growth in the coming years due to the rapid proliferation of the pharmaceuticals sector in developing regions. Empty capsules present the perfect way to deliver medication of various kinds, which has imparted them universal utility across the pharmaceuticals industry and the upward trajectory of all aspects of the healthcare sector is likely to remain a vital driver for the market in the coming years. The demand for capsules is growing on account of the mounting consumption of medicines worldwide. This trend augurs well for the global empty capsules market, where growth has thus far been driven by the demand for both nongelatin and hard gelatin capsules. The changing demographics of the world have necessitated the greater production of medicines to treat various kinds of diseases. Capsules, being among the most versatile forms of administering drug doses, are thus expected to be consumed in larger volumes over the next few years.
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Disposable Plastic Syringes

Disposable Syringes are being used by doctors to inject medicines through intravenous or intramuscular ways for the treatment of diseases & also by research & development personnel. Disposable syringes are made of plastic material and are used in the field of medical and veterinary science. The manufacture of plastic syringes has been developed to such a degree that the products now satisfy the requirements and standards set by Hospital and physicians. Disposable syringes are the dominating market with a CAGR of around 6% over the forecast period i.e. 2016-2024 because disposable syringes are used only once ensuring the safety of patients. On the basis of material, glass syringe is dominating the segment and is expected to reach a value of USD 15 million by 2024 because they can be sterilized and reused. The syringes market is expected to reach USD 15.99 Billion by 2021 from USD 10.56 Billion in 2016, at a CAGR of 8.7% during the forecast period. Thus, due to demand it is best to invest in this project. Few Indian major players are as under • Albert David Ltd. • Disposable Medi-Aids Ltd. • Hindustan Syringes & Medical Devices Ltd. • Lifeline Injects Ltd. • Lifelong Meditech Ltd. • Oyster Medisafe Pvt. Ltd. • Peekay Mediequip Ltd.
Plant capacity: Disposable Plastic Syringes 2 ml Size: 60 Boxes/Day Disposable Plastic Syringes 5 ml Size: 60 Boxes/Day Disposable Plastic Syringes 10 ml Size: 40 Boxes/DayPlant & machinery: Rs. 137 lakhs
Working capital: -T.C.I: Cost of Project: Rs 307 lakhs
Return: 13.00%Break even: 61.00%
Add to Inquiry Add to Inquiry Basket

IV Fluids (BFS Technology)

Intravenous fluids are fluids which are intended to be administered to a patient intravenously, directly through the circulatory system. These fluids must be sterile to protect patients from injury, and there are a number of different types available for use. Intravenous fluids can also be used as a route of medication administration. The market for Intravenous (IV) Solution is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer. Entrepreneurs who invest in this project will be successful.
Plant capacity: IV Fluids (500 ml Bottle): 40000 Pcs/day Plant & machinery: Rs 2734 lakhs
Working capital: -T.C.I: Cost of Project: Rs 3712 lakhs
Return: 26.00%Break even: 48.00%
Add to Inquiry Add to Inquiry Basket

Acyclovir

Aciclovir (ACV), also known as acyclovir, is an antiviral medication. It is primarily used for the treatment of herpes simplex virus infections, chickenpox, and shingles. Other uses include prevention of cytomegalovirus infections following transplant and severe complications of Epstein-Barr virus infection. It can be taken by mouth, applied as a cream, or injected. Acyclovir is an antiviral drug. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Acyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. Acyclovir is approved by the Food and Drug Administration as a prescription drug that is commonly used as a topical, inject able, and oral treatment for genital herpes and cold sores. Herpes refers to a group of viruses that cause a variety of herpes infections including genital herpes, shingles, chicken pox (also chickenpox), cold sores, and encephalitis (inflammation of the brain). The acyclovir market is segmented on the basis of types of herpes virus, mechanism of action, application, and region. On the basis of types of virus they are segmented into herpes simplex virus type I (HSV-1), herpes simplex virus type II (HSV-2), Varicella zoster virus (VZV), Epstein-Barr virus (EBV), and cytomegalovirus (CMV). Based on mechanism of action, the market is segmented into nucleotide polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, and others.
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Cloxacillin

Cloxacillin is an antibiotic useful for the treatment of a number of bacterial infections. This includes impetigo, cellulitis, pneumonia, septic arthritis, and otitis externa. It is not effective for methicillin-resistant Staphylococcus aureus (MRSA). It is used by mouth and by injection. Cloxacillin is used to treat a wide variety of bacterial infections. This medication is a type of penicillin antibiotic. It works by stopping the growth of bacteria. Cloxacillin is a penicillin-like antibiotic used for treating bacterial infections of the skin, bone, heart valves, blood, lungs, etc. caused by susceptible bacteria. This medicine is not recommended for treating common cold, flu or other viral infections since it is not effective in treating them. Cloxacillin is a semisynthetic beta-lactamase resistant penicillin antibiotic with antibacterial activity. Cloxacillin binds to and inactivates penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall, thereby preventing the cross-linkage of peptidoglycans, which are critical components of the bacterial cell wall. This leads to an interruption of the bacterial cell wall and causes bacterial cell lysis. • Global Cloxacillin Market share assessments for the regional and country level segments • Global Cloxacillin Market share analysis of the top industry players • Strategic recommendations for the new entrants • Global Cloxacillin Market forecasts for a minimum of 4 years of all the mentioned segments, sub segments and the regional markets.
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Amoxicillin

Amoxicillin is an antibiotic often used for the treatment of a number of bacterial infections. It may be used for middle ear infection, strep throat, pneumonia, skin infections, and urinary tract infections among others. It is taken by mouth, or less commonly by injection. Amoxicillin belongs to a group of drugs called the penicillins. They originate from a form of fungi called Penicillium fungi. Amoxicillin fights bacteria and stops them from growing by preventing them from forming cell walls. This kills the bacteria and eventually eradicates the infection. Amoxicillin is the generic form of the brand-name drug Amoxil, a drug used to treat bacterial infections. Doctors prescribe amoxicillin to treat infections caused by bacteria that are sensitive to the drug, including E. coli, staphylococcus, streptococcus, H. influenzae, and H. pylori. Amoxicillin is also sometimes used together with another antibiotic called clarithromycin (Biaxin) to treat stomach ulcers caused by Helicobacter pylori infection.
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Ampicillin

Ampicillin is an antibiotic used to prevent and treat a number of bacterial infections, such as respiratory tract infections, urinary tract infections, meningitis, salmonellosis, and endocarditis. It may also be used to prevent group B streptococcal infection in newborns. It is used by mouth, by injection into a muscle, or intravenously. Like all antibiotics, it is not useful for the treatment of viral infections. Ampicillin is used to treat a wide variety of bacterial infections. It is a penicillin-type antibiotic. It works by stopping the growth of bacteria. Ampicillin comes as a capsule and a suspension (liquid) to take by mouth. It is usually taken three to four times a day, either half an hour before or two hours after meals. The length of your treatment depends on the type of infection that you have. Take ampicillin at around the same times every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take ampicillin exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor. Ampicillin is a broad-spectrum, semi-synthetic, beta-lactam penicillin antibiotic with bactericidal activity. Ampicillin binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This interrupts bacterial cell wall synthesis and results in the weakening of the bacterial cell wall and causes cell lysis. Ampicillin is stable against hydrolysis by a variety of beta-lactamases, therefore, can be used in wide range of gram-positive and -negative infections. The global ampicillin market is driven by factors such as new product innovations and increasing R&D investments by major players. Moreover, regulatory concerns to control the antibiotic resistance problem are also expected to drive the global ampicillin market. Rising geriatric population is one of the key drivers for the growth of the global ampicillin market.
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Aluminium Hydroxide Gel

Aluminium hydroxide is a typical antacid active. It can be used alone or in combination with magnesium hydroxide to obtain the desired acid neutralizing capacity (ANC). Aluminium hydroxide as an antacid is not exactly an Aluminium hydroxide (Al(OH)3). Aluminium hydroxide gels are amorphous in nature and contain carbonate in the gel structure. The presence of carbonate increases the reactivity of the Aluminium, allowing for its acid-neutralizing capacity and making it a more effective antacid. Aluminium hydroxide gels and powders are available worldwide and provides the consistent quality required for pharmaceutical use. Aluminium hydroxide, Al(OH)3, is found in nature as the mineral gibbsite (also known as hydrargillite) and its three much rarer polymorphs: bayerite, doyleite, and nordstrandite. Aluminium hydroxide is amphoteric in nature, i.e., it has both basic and acidic properties. Closely related are aluminium oxide hydroxide, AlO(OH), and aluminium oxide or alumina (Al2O3), the latter of which is also amphoteric. These compounds together are the major components of the aluminium ore bauxite. Aluminum hydroxide is used to treat heartburn, upset stomach, sour stomach, or acid indigestion. Aluminum hydroxide is also used to reduce phosphate levels in people with certain kidney conditions. Aluminum hydroxide may also be used for purposes not listed in this medication guide. The global aluminum hydroxide market is expected to witness a CAGR of approximately 4.6% during the forecasted period.Aluminum hydroxides find application as fire retardants in polymer applications, as these compounds address the need for safety, durability, and insulation in many applications. Aluminium hydroxide (Gel) I.P. is used as an antacid and protective in the treatment of peptic ulcers. It is also used as astringent & antiseptic in cases of marked hyper acidity. It is used externally as a mild astringent and desiccant, and internally as an antacid and protective agent. Aluminium hydroxide is generally used in combination with other similar chemicals like Magnesium hydroxide & Magnesium trisilicate in the form of powder or paste, depending upon the final product i.e. tablet or suspension. Global Aluminum Hydroxide Gel Market is expected to gain a positive CAGR in the forthcoming period. Aluminum hydroxide gel is a naturally occurring mineral comprising three layers namely polymorphs, bayerite, doyleite&nordstrandite. Aluminum hydroxide gel is also known as gibbsite. Gibbsite possess a typical metal hydroxide structure comprised with hydrogen bombs.
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Fructose Syrup Production from Broken Rice

Fructose Syrup Production from Broken Rice. High Fructose Rice Syrup (HFS 90%) Manufacturing Business This is a natural sweetener produced by adding enzymes that convert the starch of rice into sugar. The Rice Fructose Syrup is widely used in beverages, fruit drinks, carbonated drinks, cakes, breads, jams, tinned fruits and dairy foods. Rice Fructose Syrup is a natural sweetener made from rice of Oryza Sativa (Asian Rice) origin, which is Allergen Free and Non GMO. Rice Fructose syrup can be made with either conventional rice or organic rice. Rice Fructose finds wide application in health foods and beverages, due to its inherent nature of being ‘Natural’, ‘Non GM’, ‘Allergen Free’, ‘Gluten Free’ ‘Organic’ and has ‘Low Glycemic Index’ (fewer calories). Being a plant source, Rice Fructose is suitable for ‘Vegan’ and ‘Vegetarian’ foods. Rice Fructose makes a great base for pollen-free table top sweeteners, such as pancake syrup, breakfast sweetener, honey substitute, etc. Rice Fructose is a good bulking agent for natural and blended sweeteners. Rice Fructose is a perfect healthy alternate to High Fructose Corn Syrup. Rice Fructose Syrup is very sweet with Fructose content ranging from 40-90%. As a substitute of sucrose, Rice Fructose syrup contains higher sweetness than sucrose and has wider applications. Commercially it is widely used in food, canned fruit, jam, dairy products, beverage, tobacco, cold drink, fruit juice, preserved fruit, wines, heath food, salad dressings, household seasonings and chemicals. High Fructose Rice Syrup can partially or totally replace sucrose in beverage production or food processing. Market Outlook The increasing use of rice syrup in developing an alternative ingredient for table sugar and sweeteners has fuelled its popularity among consumers in recent years. Growing demand for organic and natural sweeteners has been observed, owing to the increasing health consciousness among consumers and product developers. However, there are very few natural sweeteners available in the market right now. Due to this, it is expected that there will be launches of new products with natural ingredients, such as rice syrup, which is anticipated to drive the growth of the global rice syrup market during the forecast period. In Europe, rice syrup is the most preferred natural sweetener used in food processing industries. There has been rising demand for rice syrup from food service industries such as hotels, quick service restaurants, and cafes in recent years. As a natural sweetener, rice syrup plays an important role in providing sufficient sweetness to various foods such as pancakes, muffins, salads, chilled beverages, and others, making them delicious succulents. In the food service industry, rice syrups are also used for dressing and decorating these foods in order to attract consumers. On the basis of the regional outlook, organic rice syrup market is segmented into seven different regions: North America, Latin America, Western Europe, Eastern Europe, Japan, Middle East and Africa and Asia Pacific excluding Japan. On analyzing the organic rice syrup market at the global level, North America followed by Europe is expected to have the significant growth owing to the growing health consciousness among consumers along with growing demand for organic food products. While Asia is expected to possess potential market for organic rice syrup attributed to the increasing population of people those who are concerned about their health and consumers finding an alternative to table sugar which is less harmful. Latin America and the Middle East and Africa are expected to have the considerable growth in the near future owing to increasing demand for nutritive sweetener as well as food additives in the region. Tags #Rice_Fructose_Syrup, #Production_of_Fructose_Syrup_from_Broken_Rice, #Production_of_High_Fructose_Rice_Syrup, #High_Fructose_Rice_Syrup_Production, #Production_of_Fructose_Syrup, #Rice_Syrup_Production, Rice Syrup Processing, High-Fructose Syrups (HFS), Rice Syrup, Syrup Production, High Fructose Rice Syrup Manufacture, High Fructose Syrup, #Manufacturing_of_High_Fructose_Rice_Syrup, Production of High Fructose Syrup from Rice, Fructose Syrup Production, Fructose Syrup from Broken Rice (HFS 90%) Manufacturing Plant, Rice Syrup and Fructose, Syrup Manufacturing Process, High Fructose Rice Syrup, Organic Rice Fructose Syrup, Project Report on Fructose Syrup manufacturing Industry, Detailed Project Report on High Fructose Rice Syrup Production, #Project_Report_on_Fructose_Rice_Syrup_Production, Pre-Investment Feasibility Study on Fructose Rice Syrup Production, Techno-Economic feasibility study on Fructose Rice Syrup Production, #Feasibility_report_on_Fructose_Rice_Syrup_Production, #Free_Project_Profile_on_Fructose_Rice_Syrup_Production, Project profile on High Fructose Rice Syrup Production, Download free project profile on High Fructose Rice Syrup Production, High Fructose Rice Syrups Production Business, How to start a Fructose Rice Syrup Manufacturing Business, Pharmaceutical Syrup, Invertose, Broken Rice Flour Glucose Syrup Production Machine, Raw Rice Broken Rice Processing Fructose Syrup Produce
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Natural Glycerin Manufacturing Industry

Natural Glycerin Manufacturing Industry. Start a Glycerol/ Glycerine Production Business. Global market is expected to reach $3.12 billion by 2021 Glycerin, also referred to as glycerol or 1, 2, 3-propanetriol, is a polyhydric alcohol and part of triglycerides mainly found in vegetable and animal oil. Glycerin is derived either from natural resources or from petroleum feedstock. It is a byproduct generated during the manufacturing of biodiesel and soap. Some of the prominent applications of Glycerin include its use for moisture retention or as humectant in personal care. It is also used in medical formulations and industrial chemical manufacturing. Pharmaceutical application will continue to dominate the market for glycerin during the forecast period. Glycerin is an important raw material used for manufacturing products such as creams, jellies, eye-drops, syrups, and lozenges among others due to its smoothening, moisturizing, and sweetening properties. Increase in spending on medication and rising use of new and expensive medicinal products due to increasing health concern has propelled the consumption of pharmaceutical products in the recent years. Glycerin is mainly used in cosmetics and personal care products to enhance the smoothness and moisture content of the skin. It is found in facial moisturizer, body lotion, sunscreen, makeup, hair care, facial treatments, shaving cream etc. It acts as a humectant that prevents the premature loss of moisture from cosmetic products and it has a cooling effect on the skin. Growing awareness about skin challenges, urge to maintain an even skin tone, demand for anti-aging skin cosmetics and desire to look beautiful and young is driving the product sales, allow deeper penetration and expansion into newer markets. Moreover, increasing product demand from pharmaceutical end-user, will help the glycerin market to further grow till the end of forecast period. Market Outlook The global glycerin market is projected to reach $3.12 billion by 2021, at a CAGR of 6.8% from 2016 to 2021, in terms of value. The global glycerin industry is witnessing growth due to increasing applications, technological advancements, and increasing demand in the Asia-Pacific region, mainly from China, India, and South East Asia. The single most long term growth potential for glycerin in the personal care segment is from the rapid urbanization, increasing disposable incomes, and growing preference for natural ingredients among consumers. However, oversupply and low profitability may hamper the growth of the glycerin market. The industrial applications represent the bulk of the demand for glycerine. High demand for glycerin in toothpaste, facial creams, and other cosmetics is expected to benefit its market in the personal care industry during the forecast period. Glycerin is used for pharmaceutical and medical preparations, mainly as means for improving smoothness, providing lubrication, and humectants. It is used in cough syrups, elixirs, and expectorants. Glycerin is used for excipient uses only in the personal care industry, and serves as a humectant, solvent, and lubricant. It is used as a moisturizing agent in facial creams and other cosmetic products to keep the skin soft and replace skin moisture. It is the basic media for toothpaste which maintains its desired smoothness and viscosity and gives shine to the paste. Increasing awareness among consumers regarding the benefits of natural ingredients is expected to benefit the growth of the glycerin market in the personal care, pharmaceuticals & healthcare, and food & beverages segments. Increasing scope of application of glycerin in producing chemical intermediates is also expected to drive demand during the forecast period. Based on end-use industries, global glycerin market can be segmented into food & beverages, pharmaceuticals & healthcare, personal care, and others such as automotive, etc. The extensive use of the product in the personal care segment as a thickening agent, emulsifier, lubricant, and humectant will contribute to the growth of this segment. The additional advantages such as low toxicity and solubility will also supplement the glycerin market growth. Based on source, glycerin market is segmented into vegetable oils, bio-diesel, synthetic and others such as soaps, fatty acids etc. Biodiesel has become a major source of crude glycerin attributed to the advancement of transesterification and will significantly accelerate the glycerin market growth. An increasing production of biodiesel and the regulations related to it; rising efforts towards the development of novel applications; and a growing preference and demand for bio-renewable chemicals are factors that are likely to boost the growth of the global glycerin market over the forecast period. However, fluctuations in supply as well as availability of substitutes is likely to hinder growth of the global glycerin market over the forecast period. Global glycerin manufacturers include Emery Oleochemicals (Malaysia), IOI Oleochemicals (Malaysia), Wilmar International (Singapore), KLK Berhad (Malaysia), Godrej Industries (India), Croda International Plc (U.K.), Cargill Incorporated (U.S.), P&G Chemicals (U.S.), Kao Corporation (Japan), and Avril Group (France), among others. Tags #Production_of_Glycerin, #Manufacture_of_Glycerine_in_India, How to Make Glycerine (Glycerol), How to Make Glycerin, #Glycerine_Manufacturing_Plant, How is Glycerol Made? Glycerine Manufacturing Process Pdf, Manufacturing of Glycerin, Glycerin or Glycerol, Process of Manufacture of Glycerin, #Glycerin_Production_Process, #Start_a_Glycerin_Making_Business, Glycerine Manufacture, Natural Glycerine, #Project_Report_on_Glycerine_Manufacturing_Industry, Detailed Project Report on Glycerin Production, Project Report on Glycerin Production, #Pre_Investment_Feasibility_Study_on_Glycerin_Production, Techno-Economic feasibility study on Glycerine Manufacturing, #Feasibility_report_on_Glycerin_Production, Free Project Profile on Glycerine Manufacturing, Project profile on Glycerin Production, #Download_free_project_profile_on_Glycerin_Production, #Production_of_Natural_Glycerine, Glycerol production, How is Glycerol Made? Production of Glycerol, Manufacturing Process for Glycerol
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Information
  • One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
  • One Crore is equivalent to ten million (10,000,000)
  • T.C.I is Total Capital Investment
  • We can modify the project capacity and project cost as per your requirement.
  • We can also prepare project report on any subject as per your requirement.
  • Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Page 19 of 20 | Total 199 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20   Next »

About NIIR PROJECT CONSULTANCY SERVICES

Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

^ Top